Table 1.

Patient Characteristics.

Patient	Age	Gender	Race	Infarct	LVEF	AAD	ACE/ ARB	BB	Digoxin	VT
Ischemic Cardiomyopathy
1	80	Male	White	Inferior	33		Yes	Yes
2	66	Male	White	Inferolateral	17	Amiodarone	Yes	Yes		Yes
3	48	Male	White	Apical	17	Amiodarone	Yes	Yes	Yes	Yes
4	62	Male	White	Inferobasal	30	Amiodarone Mexiletine	Yes	Yes		Yes
5	71	Male	White	Anteroapical	27	Amiodarone Mexiletine	Yes	Yes	Yes	Yes
6	27	Female	Black	Apical	10	Amiodarone	Yes	Yes		Yes
7	50	Male	White	Inferobasal	23	Sotalol	Yes	Yes	Yes	Yes
8	68	Male	White	Anteroapical	20	Amiodarone	Yes	Yes		Yes
9	52	Male	Other	Inferoapical	32		Yes	Yes
10	85	Male	White	Inferior	40		Yes	Yes	Yes
11	76	Male	White	Inferolateral	35		Yes	Yes
12	77	Male	White	Inferolateral	40		Yes	Yes
13	66	Male	White	Inferoseptal	32	Amiodarone	Yes	Yes		Yes
14	74	Male	White	Inferoseptal	24	Amiodarone	Yes	Yes		Yes
15	58	Male	White	Apical	15	Amiodarone	Yes	Yes
16	52	Male	White	Anterior	30	Sotalol	Yes	Yes		Yes
17	59	Male	White	Inferior	33	Amiodarone	Yes	Yes		Yes
18	60	Male	White	Apical	55		Yes	Yes		Yes
19	50	Male	White	Anteroapical	35		Yes	Yes
20	55	Male	White	Anteroapical	34		Yes	Yes
21	50	Female	White	Anteroapical	35		Yes	Yes
22	64	Male	Black	Septal	45		Yes	Yes
23	62	Male	White	Apical	15		Yes	Yes	Yes
24	76	Male	White	Septal	35		Yes	Yes

AAD: antiarrhythmic drug; ACE: angiotensin converting enzyme-inhibitor; ARB: angiotensin receptor-blocker; BB: beta-blocker; LVEF: left ventricular ejection fraction; VT: ventricular tachycardia